Cancer Research Meeting Calendar  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fehrenbacher, N.
Right arrow Articles by Jäättelä, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fehrenbacher, N.
Right arrow Articles by Jäättelä, M.
Related Collections
Right arrow Therapeutics and Targets
Right arrow Therapeutics and Targets: Identification, Validation, and Markers
[Cancer Research 65, 2993-2995, April 15, 2005]
© 2005 American Association for Cancer Research


Reviews

Lysosomes as Targets for Cancer Therapy

Nicole Fehrenbacher and Marja Jäättelä

Danish Cancer Society, Apoptosis Department, Institute of Cancer Biology, Copenhagen, Denmark

Requests for reprints: Nicole Fehrenbacher, Danish Cancer Society, Apoptosis Department, Institute of Cancer Biology, Strandboulevarden 49, DK-2100 Copenhagen, Denmark. E-mail: nf{at}cancer.dk.

Tumor invasion and metastasis are associated with altered lysosomal trafficking and increased expression of the lysosomal proteases termed cathepsins. Emerging experimental evidence suggests that such alterations in lysosomes may form an "Achilles heel" for cancer cells by sensitizing them to death pathways involving lysosomal membrane permeabilization and the release of cathepsins into the cytosol. Here, we highlight recent results on cancer-related changes in the composition and function of lysosomes, focusing on possible implications for the development of novel cancer therapeutics that target tumor cell lysosomes.




This article has been cited by other articles:


Home page
J. Virol.Home page
Y.-H. Tsai, M.-F. Wu, Y.-H. Wu, S.-J. Chang, S.-F. Lin, T. V. Sharp, and H.-W. Wang
The M Type K15 Protein of Kaposi's Sarcoma-Associated Herpesvirus Regulates MicroRNA Expression via Its SH2-Binding Motif To Induce Cell Migration and Invasion
J. Virol., January 15, 2009; 83(2): 622 - 632.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Lerdrup, S. Bruun, M. V. Grandal, K. Roepstorff, M. M. Kristensen, A. M. Hommelgaard, and B. van Deurs
Endocytic Down-Regulation of ErbB2 Is Stimulated by Cleavage of Its C-Terminus
Mol. Biol. Cell, September 1, 2007; 18(9): 3656 - 3666.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. D. Nascimento, M. A. F. Hayashi, A. Kerkis, V. Oliveira, E. B. Oliveira, G. Radis-Baptista, H. B. Nader, T. Yamane, I. L. dos Santos Tersariol, and I. Kerkis
Crotamine Mediates Gene Delivery into Cells through the Binding to Heparan Sulfate Proteoglycans
J. Biol. Chem., July 20, 2007; 282(29): 21349 - 21360.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. S. Carew, S. T. Nawrocki, C. N. Kahue, H. Zhang, C. Yang, L. Chung, J. A. Houghton, P. Huang, F. J. Giles, and J. L. Cleveland
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance
Blood, July 1, 2007; 110(1): 313 - 322.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. Kitareewan, B. D. Roebuck, E. Demidenko, R. D. Sloboda, and E. Dmitrovsky
Lysosomes and Trivalent Arsenic Treatment in Acute Promyelocytic Leukemia
J Natl Cancer Inst, January 3, 2007; 99(1): 41 - 52.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Kroemer, L. Galluzzi, and C. Brenner
Mitochondrial Membrane Permeabilization in Cell Death
Physiol Rev, January 1, 2007; 87(1): 99 - 163.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
D. E. Sleat, Y. Wang, I. Sohar, H. Lackland, Y. Li, H. Li, H. Zheng, and P. Lobel
Identification and Validation of Mannose 6-Phosphate Glycoproteins in Human Plasma Reveal a Wide Range of Lysosomal and Non-lysosomal Proteins
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1942 - 1956.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. D. Petty, K. M. Kerr, G. I. Murray, M. C. Nicolson, P. H. Rooney, D. Bissett, and E. S.R. Collie-Duguid
Tumor Transcriptome Reveals the Predictive and Prognostic Impact of Lysosomal Protease Inhibitors in Non-Small-Cell Lung Cancer
J. Clin. Oncol., April 10, 2006; 24(11): 1729 - 1744.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.